"There is a growing concept of pandemic patent pooling. Patent shouldn't be enforced during such times because it allows companies to develop vaccines, which are approved at speed. There is a need for a pandemic patent pool to allow companies to develop vaccines if they can at speed and scale," says Kiran Mazumdar Shaw, Executive Chairperson, Biocon, to NDTV.
